NCT04586660 2025-10-01Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the BoneAmgenPhase 4 Active not recruiting36 enrolled
NCT03301857 2024-05-20Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004AmgenPhase 4 Completed85 enrolled 13 charts